 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or delete d from the law by 
amendment.             *hb0996*      
HOUSE BILL 996  
J1   5lr2596  
      
By: Delegate Bhandari  Delegates Bhandari, Pena –Melnyk, Cullison, Alston, 
Bagnall, Chisholm, Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kerr, 
Kipke, Lopez, Martinez, M.  Morgan, Reilly, Rosenberg, Ross, Szeliga, 
Taveras, White  Holland, Woods, and Woorman  
Introduced and read first time: January 31, 2025  
Assigned to: Health and Government Operations  
Committee Report: Favorable with amendments  
House action: Adopted  
Read second time: February 27, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Public Health – Phenibut Consumer Protection Act  2 
(JT Alvey Phenibut Consumer Protection Act)   3 
 
FOR the purpose of requiring a retailer that prepares, distributes, sells, or exposes for sale 4 
a phenibut product to disclose the factual basis on which any representations 5 
regarding the phenibut product are made; establishing prohibitions related to the 6 
preparation, distribution, and sale of phenibut products; requiring the Maryland 7 
Department of Health, in collaboration with the Maryland Hospital Association, to 8 
report to the General Assembly, on or before a certain date, on the number of adverse 9 
health e vents observed in individuals after the use of phenibut;  and generally 10 
relating to phenibut.  11 
 
BY adding to  12 
 Article – Health – General  13 
Section 21 –2F–01 through 21 –2F–04 to be under the new subtitle “Subtitle 2F. 14 
Phenibut Consumer Protection Act”  15 
 Annotat ed Code of Maryland  16 
 (2023 Replacement Volume and 2024 Supplement)  17 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 18 
That the Laws of Maryland read as follows:  19 
 
2 HOUSE BILL 996   
 
 Article – Health – General  1 
 
SUBTITLE 2F. PHENIBUT CONSUMER PROTECTION ACT. 2 
 
21–2F–01. 3 
 
 (A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE  THE MEANINGS 4 
INDICATED . 5 
 
 (B) “PHENIBUT PRODUCT ” MEANS A PRODUCT MARK ETED FOR HUMAN 6 
CONSUMPTION  CONTAINING ANY BETA –PHENYL –GAMMA–AMINOBUTYRIC ACID 7 
HCL. 8 
 
 (C) (1) “RETAILER ” MEANS A PERSON THAT : 9 
 
   (I) SELLS , PREPARES , OR MAINTAINS PHENIBU T PRODUCTS ; 10 
OR 11 
 
   (II) ADVERTISES , REPRESENTS , OR HOLDS ITSELF OUT AS 12 
SELLING , PREPARING , OR MAINTAINING PHENI BUT PRODUCTS . 13 
 
  (2) “RETAILER ” INCLUDES A MANUFACTU RER, WHOLESALER , STORE , 14 
RESTAURANT , HOTEL , CATERING FACILITY , CAMP , BAKERY , DELICATESSEN , 15 
SUPERMARKET , GROCERY STORE , CONVENIENCE STORE , GAS STATION , OR FOOD OR 16 
DRINK COMPANY . 17 
 
21–2F–02. 18 
 
 (A) (1) A RETAILER THAT PREPAR ES, DISTRIBUTES , SELLS , OR EXPOSES 19 
FOR SALE A PHENIBUT PRODUCT SHALL DISCLO SE ON THE PRODUCT LABEL THE 20 
FACTUAL BASIS ON WHI CH ANY REPRESENTATIO NS REGARDING THE PHE NIBUT 21 
PRODUCT ARE MADE . 22 
 
  (2) A RETAILER MAY NOT PRE PARE , DISTRIBUTE , SELL , OR EXPOSE 23 
FOR SALE A PHENIBUT PRODUCT THAT : 24 
 
   (I) DOES NOT COMPLY WITH THE DISCLOSURE REQUIREME NT 25 
ESTABLISHED UNDER PAR AGRAPH (1) OF THIS SUBSECTION ; OR 26 
 
   (II) HAS NOT BEEN RECOGNIZ ED AS A DIETARY INGR EDIENT OR 27 
APPROVED DRUG BY THE  U.S.  FOOD AND DRUG ADMINISTRATION . 28 
 
 HOUSE BILL 996  3 
 
  (B) (1) SUBJECT TO PARAGRAPH (2) OF THIS SUBSECTION , A RETAILER 1 
MAY NOT PREPARE , DISTRIBUTE , SELL , OR EXPOSE FOR SALE A NY OF THE 2 
FOLLOWING : 3 
 
   (I) A PHENIBUT PRODUCT THA T IS ADULTERATED WIT H A 4 
DANGEROUS SUBSTANCE OTHER THAN PHENIBUT ; 5 
 
   (II) A PHENIBUT PRODUCT THA T IS CONTAMINATED WI TH A 6 
DANGEROUS SUBSTANCE OTHER THAN PHENIBUT ; OR 7 
 
   (III) A PRODUCT CONTAINING P HENIBUT THAT DOES NO T 8 
INCLUDE ON ITS PACKA GE OR LABEL THE AMOU NT OF  9 
BETA–PHENYL –GAMMA–AMINOBUTYRIC ACID HCL CONTAINED IN THE P RODUCT .  10 
 
  (2) (I) FOR THE PURPOSE OF PA RAGRAPH (1)(I) OF THIS 11 
SUBSECTION , A PHENIBUT PRODUCT I S A DULTERATED WITH A DA NGEROUS 12 
SUBSTANCE OTHER THAN  PHENIBUT IF :  13 
 
    1. THE PHENIBUT PRODUCT IS MIXED OR PACKED W ITH 14 
A SUBSTANCE OTHER TH AN PHENIBUT ; AND 15 
 
    2. THAT SUBSTANCE AFFECT S THE QUALITY OR 16 
STRENGTH OF THE PHEN IBUT PRODUCT TO A DE GREE AS TO RENDER  THE PHENIBUT 17 
PRODUCT INJURIOUS TO  A CONSUMER . 18 
 
   (II) FOR THE PURPOSE OF PA RAGRAPH (1)(II) OF THIS 19 
SUBSECTION , A PHENIBUT PRODUCT I S CONTAMINATED WITH A DANGEROUS 20 
SUBSTANCE OTHER THAN  PHENIBUT IF THE PHEN IBUT PRODUCT CONTAIN S A 21 
POISONOUS OR OTHERWI SE DEL ETERIOUS INGREDIENT OTHER THAN PHENIBUT , 22 
INCLUDING A DRUG THA T IS DESIGNATED AS A  CONTROLLED DANGEROUS  23 
SUBSTANCE UNDER TITLE 5 OF THE CRIMINAL LAW ARTICLE . 24 
 
 (C) A RETAILER MAY NOT DIS TRIBUTE , SELL , OR EXPOSE FOR SALE A  25 
PHENIBUT PRODUCT TO AN INDIVIDUAL UN DER THE AGE OF 21 YEARS . 26 
 
 (D) IN A PROSECUTION FOR A VIOLATION OF THIS SECTION , IT IS A DEFENSE 27 
THAT THE DEFENDANT R ELIED IN GOOD FAITH ON THE REPRESENTATIO NS OF A 28 
MANUFACTURER , PROCESSOR , PACKER , OR DISTRIBUTOR OF A PHENIBUT 29 
PRODUCT . 30 
 
 (E) A RETAILER THAT VIOLATES SUBSEC TION (A)(1) OF THIS SECTION IS 31 
SUBJECT TO A CIVIL P ENALTY NOT EXCEEDING : 32 
 
  (1) $1,000  FOR A FIRST VIOLATIO N; AND  33 
4 HOUSE BILL 996   
 
  
  (2) $2,000  FOR EACH SUBSEQUENT VIOLATION . 1 
 
 (F) A RETAILER THAT VIOLAT ES SUBSECTION (A)(2),  (B), OR (C) OF THIS 2 
SECTION  IS GUILTY OF A MISDE MEANOR AND ON CONVIC TION IS SUBJECT TO A  FINE 3 
NOT EXCEEDING $5,000,  IMPRISONMENT FOR NOT  MORE THAN 90 DAYS , OR BOTH . 4 
 
 (G) IN ADDITION TO ANY OT HER PENALTIES SPECIF IED IN THIS SECTION , A 5 
RETAILER WHO VIOLATE S THIS SECTION IS LI ABLE FOR  ANY CIVIL DAMAGES 6 
SUSTAINED BY THE IND IVIDUAL RESULTING FR OM THE VIOLATION . 7 
 
21–2F–03. 8 
 
 (A) A RETAILER MAY NOT DIR ECTLY OR INDIRECTLY ADVERTISE A 9 
THERAPEUTIC BENEFIT OF PHENIBUT .  10 
 
 (B) A RETAILER MAY NOT DIR ECTLY OR INDIRECTLY ADVERTISE OR 11 
MARKET PHENIB UT PRODUCTS TO MINOR S. 12 
 
 (C) IT IS A VIOLATION OF SUBSECTION (B) OF THIS SECTION FOR A 13 
RETAILER TO USE ANY OF THE FOLLOWING IN THE ADVERTISING , PROMOTION , 14 
PACKAGING , OR LABELING OF A PHE NIBUT PRODUCT : 15 
 
  (1) A CARTOON ; 16 
 
  (2) A SUPERHERO ; 17 
 
  (3) A VIDEO GA ME REFERENCE ; 18 
 
  (4) AN IMAGE OF A FOOD PR ODUCT PRIMARILY INTE NDED FOR 19 
MINORS ; 20 
 
  (5) A TRADEMARK THAT IMITA TES OR MIMICS THE TR ADEMARK OF A 21 
PRODUCT THAT HAS BEE N ADVERTISED OR MARK ETED PRIMARILY TO MI NORS ; 22 
 
  (6) A SYMBOL OR CELEBRITY THAT IS PRIMARILY AS SOCIATED WITH 23 
MINORS OR MEDIA PRIM ARILY DIRECTED TO MI NORS ; AND 24 
 
  (7) AN IMAGE OF AN INDIVI DUAL WHO APPEARS TO BE UNDER THE 25 
AGE OF 27 YEARS . 26 
 
 (D) IT IS A VIOLATION OF SUBSECTION (B) OF THIS SECTION FOR A 27 
RETAILER TO ADVERTIS E OR PROMOTE A PHENI BUT PRODUCT : 28 
 
 HOUSE BILL 996  5 
 
   (1) IN A NEWSPAPER , A MAGAZINE , A PERIODICAL , OR ANY OTHER 1 
PUBLICATION FOR WHIC H INDIVIDUALS UNDER THE AGE OF 21 YEARS CONSTITUTE 2 
15%  OR MORE OF THE TOTAL  AUDIENCE , AS MEASURED BY COMPE TENT AND 3 
RELIABLE SURVEY EVID ENCE ; 4 
 
  (2) AT A CONCERT , A STADIUM , A SPORTING EVENT , OR ANY OTHER 5 
PUBLIC EVENT FOR WHI CH INDIVIDUALS UNDER  THE AGE OF 21 YEARS CONSTITUTE 6 
15%  OR MORE OF THE TOTAL  AUDIENCE , AS MEASURED BY COMPE TENT AND 7 
RELIABLE SURVEY EVID ENCE ; OR 8 
 
  (3) ON AN OUTDOOR BILLBOA RD OR SIGN BOARD THA T IS WITHIN 500 9 
FEET OF A SCHOOL . 10 
 
21–2F–04. 11 
 
 THE DEPARTMENT SHALL ADOP T REGULATIONS TO CAR RY OUT THIS 12 
SUBTITLE . 13 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That, on or before December 31, 14 
2026, the Maryland Department of Health, in collaboration with the Marylan d Hospital 15 
Association, shall report to the General Assembly, in accordance with § 2 –1257 of the State 16 
Government Article, on the number of adverse health events observed in individuals after 17 
the use of phenibut.  18 
 
 SECTION 3. 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 19 
October 1, 2025.  20 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  
________________________________ ________________________________ ________________   
                 President of the Senate.  